Journal of Dermatological Treatment

Article	Citations
Teledermatology: a useful tool to fight COVID-19	64
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study	50
Minoxidil: a comprehensive review	48
Should patients stop their biologic treatment during the COVID-19 pandemic	43
Inpatient teledermatology during the COVID-19 pandemic	41
Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year	38
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears	38
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study	37
The danger of neglecting melanoma during the COVID-19 pandemic	37
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response	33
Dermatological consultations in the COVID-19 era: is teledermatology the key to social distancing? An Egyptian experience	30
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study	30
Melasma treatment: a systematic review	29
Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic	29
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience	29
Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life	28
‘Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study’	28
Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature	27
Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials	27
A challenging case of psoriasis flare-up after COVID-19 infection	25
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis	25
COVID-19 and psoriasis: biologic treatment and challenges	25
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase	24
Safety of dupilumab in atopic patients during COVID-19 outbreak	24
The versatility of azelaic acid in dermatology	24

Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker – a retrospective multicenter study	23
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy	23
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice	23
Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review	22
Herpes zoster (shingles) complicating the course of COVID19 infection	22
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	21
Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1	21
Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis	21
Dupilumab for the treatment of adult atopic dermatitis in special populations	21
The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature	20
JAK inhibitors in lichen planus: a review of pathogenesis and treatments	19
Antifungal resistance in superficial mycoses	18
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment	18
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?	18
Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of t	18
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population	18
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis	18
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis	18
Vehicles for atopic dermatitis therapies: more than just a placebo	17
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis	17
Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema	17
An assessment of United States dermatology practices during the COVID-19 outbreak	17
The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone	17
A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata	17
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study	16
Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial	16
Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality	16
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	16
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis	16
Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids	15
Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma	15
Finasteride for hair loss: a review	15
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study	15
COVID-19 related anagen effluvium	15
Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics	14
Conducting clinical trials during the COVID-19 pandemic	14
The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis	14
Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study	14
A survey of psoriasis patients on biologics during COVID-19: a single centre experience	14
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	14
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials	14
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials	14
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report	14
Platelet-rich fibrin and concentrated growth factors as novel platelet concentrates for chronic hard-to-heal skin ulcers: a systematic review and Meta-analysis of randomized controlled trials	14
Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance	14
Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review	13
Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients	13
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials	13
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey	13
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies	13

Topical methotrexate in dermatology: a review of the literature	13
A systematic review of evidence based treatments for lichen simplex chronicus	13
Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria	12
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines	12
The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy	12
Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis	12
A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts	12
Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial	12
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study	12
Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data	11
Cosmetic skin lightening use and side effects	11
A systematic review of antipsychotic agents for primary delusional infestation	11
Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populations	11
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors – brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry	11
A case of severe psoriatic erythroderma with COVID-19	11
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors	11
Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas	11
Are skin equipment for assessing childhood eczema any good?	11
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes	11
Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review	10
Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial	10
Effectiveness of benzyl benzoate treatment on clinical symptoms and Demodex density over time in patients with rosacea and demodicosis: a real life retrospective follow-up study comparing low- and hig	10
Baricitinib for the treatment of atopic dermatitis	10
Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany	10
COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience	10
The efficacy of rituximab in patients with mucous membrane pemphigoid	10
Onychomycosis in children – review on treatment and management strategies	10
Treatment adherence and persistence of seven commonly prescribed biologics for moderate to severe psoriasis and psoriatic arthritis in a U.S. commercially insured population	10
Egyptian dermatologists attitude toward telemedicine amidst the COVID19 pandemic: a cross-sectional study	10
A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratoses	10
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma	10
Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients’ quality of life	10
Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies	10
Dupilumab as promising treatment for prurigo nodularis: current evidences	10
Off-label dermatologic uses of IL-17 inhibitors	10
Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects#	10
Treatment of patients with chronic pruritus of unknown origin with dupilumab	9
Clinical and histopathological comparison of microneedling combined with platelets rich plasma versus fractional erbium-doped yttrium aluminum garnet (Er: YAG) laser 2940 nm in treatment of atrophic p	9
Benefits, drawbacks, and challenges of social media use in dermatology: a systematic review	9
Treatment of acne vulgaris using 1,565 nm non-ablative fractional laser in combination with isotretinoin and pricking blood therapy	9
Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis	9
The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests	9
Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets	9
Emerging treatments for bullous pemphigoid	9
Assessment of various intralesional injections in keloid: comparative analysis	9
Off-Label studies on anakinra in dermatology: a review	9
Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial	9
Treatment of keratosis pilaris and its variants: a systematic review	9
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series	9
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses	9
Systematic literature review of long-term efficacy data for topical psoriasis treatments	9
Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?	9
Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata	8
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy	8
Efficacy of curcumin for recurrent aphthous stomatitis: a systematic review	8
Predictors of drug survival of biologic therapies in psoriasis patients	8
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series	8
Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient’s satisfaction in toenail onychomycosis treatment: an intra-patient comparative single-center study	8
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition	8
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab	8
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis	8
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	8
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis	8
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection	8
Pain management modalities for hidradenitis suppurativa: a patient survey	8
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	8
Multidisciplinary management of chronic atopic dermatitis in children and adolescents: a prospective pilot study	8
Combined microneedling with topical application of platelet-rich plasma versus microneedling alone in the treatment of stria distensae: clinicopathological analysis	8
Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series	8
Herpes zoster cases increased during COVID-19 outbreak. Is it possible a relation?	8
Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review	8
Patient and caregiver preferences on treatment attributes for atopic dermatitis	8
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	8
Elderly patients with psoriasis: long-term efficacy and safety of modern treatments	8
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis	8
Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus	8
A survey-based study of physician practices regarding biotin supplementation	7
Clinical management of psoriasis patients during the COVID-19 pandemic	7
Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists	7
A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma	7

Deucravacitinib in the treatment of psoriasis	7
Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial	7
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study	7
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study	7
COVID-19: Challenges and opportunities for dermatology response	7
Pulsed dye laser versus intense pulsed light for facial erythema of rosacea: a systematic review and meta-analysis	7
Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis	7
A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders	7
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis	7
A consistent skin care regimen leads to objective and subjective improvements in dry human skin: investigator-blinded randomized clinical trial	7
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study	7
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	7
Use of systemic therapies for psoriasis in the COVID-19 era	7
Correlation of serum vitamin D levels with severity of pediatric atopic dermatitis and the impact of vitamin D supplementation on treatment outcomes	7
Cognitive behavioral therapy as an adjuvant therapy in acne excoriée: a randomized controlled clinical trial	7
Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea a randomized clinical trial	7
A time series analysis of immune checkpoint inhibitor use in the United States Medicare population: 2014–2019	7
Four-weeks daily intake of oral collagen hydrolysate results in improved skin elasticity, especially in sun-exposed areas: a randomized, double-blind, placebo-controlled trial	7
Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study	7
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series	7
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience	7
Treatment of sebaceous gland hyperplasia: a review of the literature	6
Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study	6
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis	6
Unmet needs in atopic dermatitis management: an expert consensus	6
Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis	6
A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma	6
SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19	6
COVID-19 effect on phototherapy treatment utilization in dermatology	6
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy	6
Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis	6
Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities	6
Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review	6
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity	6
Neonatal epidermolysis bullosa: lessons to learn about genetic counseling	6
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	6
Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study	6
Hyperhidrosis and the risk of being treated for skin infections	6
Long-lasting treatment for moderate-severe depressed facial scars: skin and hair derived new autologous tissue filler with subcision	6
Limb melanomas: acral melanomas have worse survival	6
Intralesional immunotherapy for the treatment of anogenital warts in pediatric population	6
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis	6
Emerging topical therapies to treat pigmentary disorders: an evidence-based approach	6
Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring	6
Examining correlation of altmetric score and citation number in dermatology journal articles	6
Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus	6
Autologous plasma gel injection combined with scar subcision is a successful technique for atrophic post-acne scars: a split-face study	6
Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective	6
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis	6
The effect of multistrain synbiotic and vitamin D3 supplements on the severity of atopic dermatitis among infants under 1 year of age: a double-blind, randomized clinical trial study	6
Value of reflectance confocal microscopy for the monitoring of rosacea during treatment with topical ivermectin	6
Apremilast as a target therapy for nail psoriasis: a real-life observational study proving its efficacy in restoring the nail unit	6
Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts	6
Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata	6
Photo-triage of infantile hemangiomas: potential to reduce healthcare exposure in the COVID19 pandemic	6
Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries	6
Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis	6
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice	6
Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries	6
Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial	6
Moderate-to-severe plaque psoriasis patients treated with ixekizumab: early real-world outcomes and adverse events	6
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?	6
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study	6